Chicago Partners Investment Group LLC Acquires 7,672 Shares of The Cooper Companies, Inc. $COO

Chicago Partners Investment Group LLC grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 297.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 10,250 shares of the medical device company’s stock after acquiring an additional 7,672 shares during the period. Chicago Partners Investment Group LLC’s holdings in Cooper Companies were worth $686,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in COO. New York Life Investment Management LLC boosted its holdings in Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares in the last quarter. Root Financial Partners LLC grew its stake in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the last quarter. Allworth Financial LP increased its holdings in shares of Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Cooper Companies by 13.9% during the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after acquiring an additional 185 shares in the last quarter. Finally, SJS Investment Consulting Inc. raised its position in shares of Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

COO opened at $71.71 on Friday. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The firm has a market cap of $13.99 billion, a P/E ratio of 60.77, a PEG ratio of 1.91 and a beta of 0.84. The company has a 50 day simple moving average of $66.24 and a two-hundred day simple moving average of $72.58.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

COO has been the topic of a number of analyst reports. Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Robert W. Baird lowered their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Citigroup reiterated a “neutral” rating and set a $76.00 target price (up from $69.00) on shares of Cooper Companies in a research note on Wednesday, July 8th. Wells Fargo & Company reissued a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Finally, Mizuho set a $85.00 price target on Cooper Companies and gave the stock an “outperform” rating in a research note on Thursday, June 4th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $81.85.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.